[1] Chalmers J,Wilkes E,Harris R,et al. The Development and Implementation of a Commissioned Pathway for the Identification and Stratification of Liver Disease in the Community. Frontline Gastroenterol,2020,11:86-92.
[2] Moolla A,Motohashi K,Marjot T,et al. A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health. Frontline Gastroenterol,2019,10:337-346.
[3] Mantovani A. Amultidisciplinary approach to non-alcoholic fatty liver disease (NAFLD) improves cardiovascular risk factors. EASL 2019:Abs P04-01YI.
[4] Neilson L J,Macdougall L,Lee P S,et al. Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease. Frontline Gastroenterol,2021,0:1-8.
[5] Devore S,Kohli R,Lake K,et al. A multidisciplinary clinical program is effective in stabilizing BMI and reducing transaminase levels in pediatric patients with NAFLD. J Pediatr Gastroenterol Nutr,2013,57:119-123.
[6] Armstrong MJ,Hazlehurst JM,Parker R,et al. Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management. QJM,2014,107:33-41.
[7] Ahmed MH,Woodward C,Mital D. Metabolic clinic for individuals with HIV/AIDS: a commitment and vision to the future of HIV services. Cardiovasc Endocrinol,2017,6:109-112.
[8] Lazarus JV,Anstee QM,Hagstr?m H,et al. Defining comprehensive models of care for NAFLD. Nat Rev Gastroenterol Hepatol,2021,18:717-729.
[9] 中国研究型医院学会肝病专业委员会,中国医师协会脂肪性肝病专家委员会,中华医学会肝病学分会脂肪肝和酒精性肝病学组,等. 脂肪性肝病诊疗规范化的专家建议(2019年修订版). 实用肝脏病杂志, 2019, 22:787-792. |
